Friday, 13 August 2021

India`s first nasal vaccine for COVID soon? Bharat Biotech`s intranasal vaccine gets nod for Phase 2/3 trials

The DBT apprised that Phase 1 clinical trial of the nasal vaccine candidate, BBV154, has been completed in age groups ranging from 18 to 60 years. 
http://dlvr.it/S5c86r

No comments:

Post a Comment